Welcome to the TIGIT Axis Therapies Digital Summit

As immuno-oncology drug development transforms cancer treatment paradigms, preclinical and clinical data continues to demonstrate that the TIGIT axis blockade, particularly in combination with other immune checkpoint inhibitor partners, has strong efficacy. Despite recent clinical setbacks, and with at least 15 anti-TIGIT axis drugs in active clinical development, TIGIT axis targeting remains a promising treatment approach.

In the context of a need to accelerate practice-changing cancer immunotherapies towards approval and to patients in need, the 3rd TIGIT Axis Therapies Summit returns to reunite large pharma, innovative biotechs and pioneering academics to discuss the full range of next-generation TIGIT axis targeted drug modalities and maximize TIGIT-axis targeting in the solid tumor, blood cancer and non-oncology setting.

Covering deciphering the mechanistic intricacies underlying TIGIT axis signaling, defining combination partners that improve efficacy and strengthen TIGIT targeted pipelines, exploring novel drug designs in terms of Fc functionality and IgG type, identifying molecular signatures relevant to the tumor microenvironment and periphery to incorporating unique pharmacology properties into trial design, this is your comprehensive guide for addressing the unique challenges of TIGIT axis targeted drug development and powering up your pipelines.

This year’s sharp two-day agenda leans into the clinical headwinds faced by so many immune checkpoint targets. As the space regroups, join the conversation to build meaningful partnerships and maximize the clinical and commercial success of the next generation of TIGIT axis targeted drugs.

View the Full Agenda Now!

A Sneak Peek at the Speaker Faculty for 2022:

Who Attended in 2021:

TIGIT Axis Therapies - Agenus
TIGIT Axis Therapies - Arcus Bio
TIGIT Axis Therapies - Beigene
TIGIT Axis Therapies - BMS
TIGIT Axis Therapies - Coherus
TIGIT Axis Therapies - Compugen
TIGIT Axis Therapies - Genentech
TIGIT Axis Therapies - Genmab
TIGIT Axis Therapies - Gilead
TIGIT Axis Therapies - Graphite Bio
TIGIT Axis Therapies - GSK
TIGIT Axis Therapies - Harvard Medical School
TIGIT Axis Therapies - Horizon
TIGIT Axis Therapies - iTeos Therapeutics
TIGIT Axis Therapies - MD Anderson
TIGIT Axis Therapies - Merck
TIGIT Axis Therapies - Mereo Biopharma
TIGIT Axis Therapies - NectinTx
TIGIT Axis Therapies - Regeneron
TIGIT Axis Therapies - Roche
TIGIT Axis Therapies - Seagen
TIGIT Axis Therapies - Shattuck Labs
TIGIT Axis Therapies - Stanford Medicine
TIGIT Axis Therapies - Yale School of Medicine

Team Discounts Available:

3 Passes - 10% Discount

4 Passes - 15% Discount

5+ Passes - 20% Discount